Hoofnagle J H, Lombardero M, Zetterman R K, Lake J, Porayko M, Everhart J, Belle S H, Detre K M
Division of Digestive Disease and Nutrition, National Institute of Diabetes and Digestive and Kidney Disease, National Institute of Health, Bethesda, MD, USA.
Hepatology. 1996 Jul;24(1):89-96. doi: 10.1002/hep.510240116.
To evaluate the effect of donor age on graft and patient outcome after liver transplantation an analysis of a large-scale cohort study was performed at three tertiary referral liver transplant centers. Between April 1990 and June 1994, 772 adults underwent an initial single-organ liver transplantation. The age of the donors averaged 35 years;193 (25%) were 50 or above, the age used to define "older" donors. Groups were compared for demographic, clinical, and biochemical features. Outcome was measured using results of biochemical tests after transplantation and by graft and patient survival. Compared with younger donors, older donors were more commonly women (59% vs. 33%:P < or = .001) and died of central nervous system causes (79% vs. 28%) as opposed to trauma (13% vs. 63%:P < or = .001). The recipients of the two groups of donor livers did not differ in important respects. However, intraoperatively, livers from older donors were more likely to be assessed as either "poor" or "fair" as opposed to "good" (17% vs. 4%:P < or = .001) by the harvesting surgeon and to have initial "poor" or "fair" bile production (29% vs. 18%:P < or = .001). During the first week postoperatively, the serum aminotransferase and bilirubin levels and prothrombin times were higher in recipients of older than those of younger donor livers. During follow-up, graft survival was less for recipients of older donor livers at 3 months (81% vs.91%:P = .0001) and at 1 (76% vs. 85%:P = .007) and 2 years (71% vs. 80%:P = .005); patient survival showed similar though less marked differences. This association of donor age and poorer graft survival persisted after adjusting for many variables using bivariate and multivariate analyses. Importantly, however, the association with poor graft survival was largely among recipients of older donor livers, the quality of which was assessed as fair or poor by the harvesting surgeon; recipients of older donor livers assessed as good had a retransplant-free survival similar to that of younger donor livers (87% vs. 91% at 3 months). Thus, use of older donor livers, the quality of which are judged to be good by the harvesting surgeon, is not associated with a decrease in patient or graft survival after liver transplantation. differences. This association of donor age and poorer graft survival persisted after adjusting for many variables using bivariate and multivariate analyses. Importantly, however, the association with poorer graft survival was largely among recipients of older donor livers, the quality of which was assessed as fair or poor by the harvesting surgeon; recipients of older donor livers, the quality of which was assessed as fair or poor by the harvesting surgeon; recipients of older donor livers assessed as good had a retransplant-free survival similar to that of younger donor livers (87% vs. 91% at 3 months). Thus, use of older donor livers, the quality of which are judged to be good by the harvesting surgeon, is not associated with a decrease in patient or graft survival after liver transplantation.
为评估供体年龄对肝移植后移植物及患者预后的影响,在三家三级转诊肝移植中心对一项大规模队列研究进行了分析。1990年4月至1994年6月期间,772名成人接受了初次单器官肝移植。供体平均年龄为35岁;193名(25%)供体年龄在50岁及以上,该年龄被用来定义“老年”供体。对两组在人口统计学、临床和生化特征方面进行了比较。通过移植后生化检测结果以及移植物和患者生存率来衡量预后。与年轻供体相比,老年供体中女性更为常见(59%对33%:P≤0.001),且死于中枢神经系统疾病(79%对28%)而非创伤(13%对63%:P≤0.001)。两组供体肝脏的受者在重要方面并无差异。然而,在术中,与“良好”肝脏相比,来自老年供体的肝脏更有可能被采集外科医生评估为“差”或“一般”(17%对4%:P≤0.001),并且初始胆汁生成“差”或“一般”的比例更高(29%对18%:P≤0.001)。术后第一周,接受老年供体肝脏的受者血清转氨酶、胆红素水平及凝血酶原时间高于接受年轻供体肝脏的受者。在随访期间,接受老年供体肝脏的受者在3个月时移植物存活率较低(81%对91%:P = 0.0001),在1年(76%对85%:P = 0.007)和2年时也是如此(71%对80%:P = 0.005);患者生存率也有类似差异,不过差异不太明显。在使用双变量和多变量分析对多个变量进行调整后,供体年龄与较差的移植物存活率之间的这种关联依然存在。然而,重要的是,与较差移植物存活率的关联主要存在于接受老年供体肝脏的受者中,这些肝脏被采集外科医生评估为质量一般或较差;而被评估为质量良好的老年供体肝脏受者的无再次移植生存率与年轻供体肝脏受者相似(3个月时为87%对91%)。因此,使用被采集外科医生判断为质量良好的老年供体肝脏,与肝移植后患者或移植物存活率的降低并无关联。差异。在使用双变量和多变量分析对多个变量进行调整后,供体年龄与较差的移植物存活率之间的这种关联依然存在。然而,重要的是,与较差移植物存活率的关联主要存在于接受老年供体肝脏的受者中,这些肝脏被采集外科医生评估为质量一般或较差;被评估为质量良好的老年供体肝脏受者的无再次移植生存率与年轻供体肝脏受者相似(3个月时为87%对91%)。因此,使用被采集外科医生判断为质量良好的老年供体肝脏,与肝移植后患者或移植物存活率的降低并无关联。